Cyanobacteria Natural Products as Sources for Future Directions in <em>Antibiotic</em> Drug Discovery
Cyanobacteria, an abundant source of natural products with a broad diversity of secondary metabolites, have emerged as a novel resource for the progression of synthetic analogs. Due to the rise of antibiotic resistance, there is a need for new medications and cyanobacteria-derived compounds have sho...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/84038 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Cyanobacteria, an abundant source of natural products with a broad diversity of secondary metabolites, have emerged as a novel resource for the progression of synthetic analogs. Due to the rise of antibiotic resistance, there is a need for new medications and cyanobacteria-derived compounds have shown promising important alternatives for new therapeutics. These secondary metabolites are produced through nonribosomal peptide synthetase (NRPS), polyketide synthase (PKS), and mainly through mixed NRPS-PKS enzymatic systems. Current research is focused on the exploitation of cyanobacteria for the production of bioactive metabolites. Screening of cyanobacteria for pharmaceutically active compounds has received increasing attention; however, limited knowledge is available on biosynthetic mechanisms that would enhance the drug discovery process and culture-based production of desired metabolites. Overall, there is a promising outlook that cyanobacterial secondary metabolites will become alternatives for the development of new medications in a near future with enhanced pharmacological and pharmacokinetic properties. |
|---|---|
| ISBN: | 978-1-80356-461-6 |
| DOI: | 10.5772/intechopen.106364 |